Impact of hospital acquired infections on post-transplant one year mortality in pediatric bone marrow transplant patients.

American Journal of Infection Control
Benjamin R HanischXiaoyan Song

Abstract

Children undergoing hematopoietic stem cell transplant (HSCT) are prone to infections, especially when hospitalized for the transplant or additional medical care. These infections are perceived to increase patient's mortality risk, but data are lacking. We conducted this study to assess the burden and the impact of hospital acquired infections (HAI) on mortality risk among pediatric HSCT patients. This retrospective study included 169 patients that received allogeneic HSCT between January 1 2011 and July 6 2017 at Children's National Hospital, a tertiary referral center. Clinical and laboratory data were reviewed for 1 year after transplant to determine HAI and survival status. The HAI incident rates stratified by bloodstream, respiratory, and gastrointestinal infections were then compared between deceased patients and survivors. Including transplant, 169 patients sustained 499 hospital admissions for total of 10,523 patient days and 112 HAI episodes, resulting in a HAI rate of 10.6 per 1,000 patient-days. Within 1-year after transplant, 38 (22%) patient died, 30 (17.5%) with nonrelapse-related causes. Unadjusted univariate analysis revealed mortality correlated with cell source (p=0.035), donor type (p = 0.002), respiratory vi...Continue Reading

References

Oct 9, 2002·Journal of Virology·C T GarnettLinda R Gooding
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Oct 29, 2009·Bone Marrow Transplantation·D YokoeUNKNOWN Centers for Disease Control and Prevention
Sep 15, 2010·Blood·Caroline A LindemansJaap Jan Boelens
Jan 1, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·O BlennowM Remberger
Oct 24, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Jan StyczynskiUNKNOWN Polish Society of Paediatric Oncology and Haematology
Dec 8, 2015·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Elena BeamRaymund R Razonable
Dec 30, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K KosulinT Lion
Jun 28, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Ugur SahinTaner Demirer
Aug 3, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anthony D SungMitchell E Horwitz
Sep 16, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Kelsey A SokolAmir Steinberg
Jul 1, 2017·Current Opinion in Infectious Diseases·Yeon Joo LeeGenovefa A Papanicolaou
Oct 28, 2017·Frontiers in Immunology·Amy Houghtelin, Catherine M Bollard
Mar 14, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Starling A SimBenjamin W Teh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2021 Meta ULC. All rights reserved